Technology & Innovation
Explore Generic CT and MRI Contrast Agents at AHRA 2026, Booth #620
July 01, 2026 - Fresenius Kabi
The following is sponsored content from Fresenius Kabi.
Rising imaging volumes and tightening budgets are prompting radiology and pharmacy teams to evaluate opportunities to manage contrast agent costs while maintaining quality patient care.
When you partner with Fresenius Kabi, you gain access to FDA-approved generic contrast agents that are fully substitutable to brand-name products — at a lower cost.
Our generic contrast agents provide healthcare providers like you with additional options when making purchasing and formulary decisions. Now you have a choice.
Learn More About Transitioning to Generic Contrast Agents
Download our white paper to explore the role of generics in imaging and read about real-world experiences from healthcare providers who have made the transition.
The Value of Generic Contrast Utilization in Imaging
As the leading provider of generic contrast agents, our priority is helping to ensure you have uninterrupted access to the same safe and effective contrast agent you have always relied on while helping reduce overall costs.